ATE112689T1 - Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung. - Google Patents

Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.

Info

Publication number
ATE112689T1
ATE112689T1 AT90901464T AT90901464T ATE112689T1 AT E112689 T1 ATE112689 T1 AT E112689T1 AT 90901464 T AT90901464 T AT 90901464T AT 90901464 T AT90901464 T AT 90901464T AT E112689 T1 ATE112689 T1 AT E112689T1
Authority
AT
Austria
Prior art keywords
macrocylic
formulations
manufacture
methods
acid complexes
Prior art date
Application number
AT90901464T
Other languages
English (en)
Inventor
Jaime Simon
David A Wilson
Joseph R Garlich
David E Troutner
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of ATE112689T1 publication Critical patent/ATE112689T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • C07F9/3817Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/06Chelate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90901464T 1988-12-19 1989-12-15 Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung. ATE112689T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/284,876 US5059412A (en) 1984-06-04 1988-12-19 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors

Publications (1)

Publication Number Publication Date
ATE112689T1 true ATE112689T1 (de) 1994-10-15

Family

ID=23091854

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90901464T ATE112689T1 (de) 1988-12-19 1989-12-15 Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.

Country Status (26)

Country Link
US (1) US5059412A (de)
EP (2) EP0408701B1 (de)
JP (1) JP2515929B2 (de)
KR (1) KR0178966B1 (de)
CN (1) CN1025983C (de)
AR (1) AR248140A1 (de)
AT (1) ATE112689T1 (de)
AU (3) AU639899B2 (de)
BR (1) BR8907255A (de)
CA (1) CA2005880C (de)
CY (1) CY1902A (de)
DE (1) DE68918852T2 (de)
DK (1) DK175479B1 (de)
ES (1) ES2061010T3 (de)
FI (1) FI101857B1 (de)
HK (1) HK146795A (de)
HU (1) HU207454B (de)
IE (2) IE66391B1 (de)
IL (1) IL92784A (de)
MX (1) MX18786A (de)
NO (1) NO180434C (de)
NZ (1) NZ231818A (de)
PT (1) PT92619B (de)
SA (1) SA91120234B1 (de)
WO (1) WO1990006776A1 (de)
ZA (1) ZA899734B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5645818A (en) * 1989-03-24 1997-07-08 Guerbet S.A. Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions
DE4009119A1 (de) * 1990-03-19 1991-09-26 Schering Ag 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
WO1991016075A1 (en) * 1990-04-20 1991-10-31 Australian Nuclear Science & Technology Organisation Bone marrow treatments
AU648315B2 (en) * 1990-06-18 1994-04-21 Dow Chemical Company, The The use of macrocyclic aminophosphonic acid complexes as imaging agents
MC2260A1 (fr) * 1990-06-18 1993-04-26 Dow Chemical Co Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5739294A (en) * 1991-12-10 1998-04-14 The Dow Chemical Company Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
JP3356289B2 (ja) * 1995-06-26 2002-12-16 コンキャット リミティド 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
JP2003501488A (ja) * 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
EP1390081A2 (de) 2001-01-08 2004-02-25 Neorx Corporation Therapeutische und diagnostische verbindungen, zusammenstellungen und methoden
US20020094316A1 (en) * 2001-01-09 2002-07-18 Shuang Liu Polypodal chelants for metallopharmaceuticals
WO2003051403A1 (en) * 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US20030228256A1 (en) * 2002-06-11 2003-12-11 Inverardi Luca A. Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations
WO2007008232A2 (en) 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
WO2011149844A1 (en) * 2010-05-24 2011-12-01 Iso Therapeutics Group Llc Delivery of high dose therapeutic radioisotopes to bone
US10172965B2 (en) 2013-10-07 2019-01-08 Igl Pharma, Inc. High purity therapeutic bone agents
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
WO2016191413A1 (en) 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
HRP20200922T1 (hr) 2016-09-27 2020-09-18 Bayer Pharma Aktiengesellschaft Postupak za proizvodnju kristalnog oblika modifikacije a kalkobutrola
WO2018148209A1 (en) 2017-02-08 2018-08-16 Iso Therapeutics Group, Llc Method of use for therapeutic bone agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965254A (en) * 1973-05-23 1976-06-22 The Procter & Gamble Company Compositions for the treatment of calcific tumors
US4017595A (en) * 1975-08-28 1977-04-12 Research Corporation Bone-seeking indium-113m or indium-111 organic phosphonate complexes
CA1078731A (en) * 1976-12-16 1980-06-03 Charles E. Frosst And Co. Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
DE164843T1 (de) * 1984-06-04 1989-12-07 The Dow Chemical Co., Midland, Mich. Organische aminphosphonsaeurekomplexe fuer die behandlung von verkalkenden tumoren.
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4976950A (en) * 1988-12-19 1990-12-11 The Dow Chemical Company Bone marrow suppressing agents

Also Published As

Publication number Publication date
CA2005880C (en) 1999-01-05
PT92619A (pt) 1990-06-29
PT92619B (pt) 1995-09-12
HK146795A (en) 1995-09-22
IL92784A (en) 1994-08-26
NO903632D0 (no) 1990-08-17
WO1990006776A1 (en) 1990-06-28
DE68918852T2 (de) 1995-05-11
MX18786A (es) 1993-12-01
NO180434C (no) 1997-04-23
KR0178966B1 (ko) 1999-03-20
DK195990A (da) 1990-08-16
EP0408701A1 (de) 1991-01-23
IE66391B1 (en) 1995-12-27
ZA899734B (en) 1991-08-28
AU657641B2 (en) 1995-03-16
AU639899B2 (en) 1993-08-12
EP0375376A3 (de) 1991-06-12
JPH03502936A (ja) 1991-07-04
DK175479B1 (da) 2004-11-08
EP0375376A2 (de) 1990-06-27
AU4828290A (en) 1990-07-10
CN1025983C (zh) 1994-09-28
FI101857B (fi) 1998-09-15
EP0408701A4 (en) 1991-07-31
DE68918852D1 (de) 1994-11-17
AU5068593A (en) 1994-02-24
AR248140A1 (es) 1995-06-30
HU901163D0 (en) 1991-03-28
ES2061010T3 (es) 1994-12-01
FI101857B1 (fi) 1998-09-15
KR910700073A (ko) 1991-03-13
NO180434B (no) 1997-01-13
CA2005880A1 (en) 1990-06-19
SA91120234B1 (ar) 2004-09-04
AU4700989A (en) 1990-06-21
BR8907255A (pt) 1991-03-12
EP0408701B1 (de) 1994-10-12
HU207454B (en) 1993-04-28
CY1902A (en) 1989-12-15
IL92784A0 (en) 1990-09-17
HUT54897A (en) 1991-04-29
IE940833L (en) 1990-06-19
CN1046739A (zh) 1990-11-07
DK195990D0 (da) 1990-08-16
US5059412A (en) 1991-10-22
JP2515929B2 (ja) 1996-07-10
IE894063L (en) 1990-06-19
FI904084A0 (fi) 1990-08-17
NO903632L (no) 1990-10-17
NZ231818A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
ATE112689T1 (de) Makrocylische aminophosphonsäurekomplexe, verfahren zur herstellung und formulierungen sowie verwendung.
DE3582754D1 (de) Medizinisches werkzeug und verfahren zur herstellung.
DE3879218D1 (de) Medizinisches instrument und verfahren zur herstellung.
DE3482943D1 (de) Katheter und verfahren zur herstellung.
DE3779199D1 (de) Atmungsaktive folie und verfahren zur herstellung derselben.
DE68916233D1 (de) Querstromfilteranordnung und verfahren zur herstellung.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3668782D1 (de) Kuenstliche lunge des membrantyps und verfahren zu ihrer herstellung.
DE3683869D1 (de) Zweistueckige modulsteckdose und verfahren zur herstellung derselben.
ATE108067T1 (de) Impfstoff und verfahren zur herstellung.
DE3785329D1 (de) Harzzusammensetzung und verfahren zur herstellung.
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
DE68918967D1 (de) Bipolare Transistorstruktur und Verfahren zu ihrer Herstellung.
DE3778089D1 (de) Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
ATA232687A (de) Zahnpflegemittel, sowie verfahren zur herstellung des zahnpflegemittels
DE3885387D1 (de) Verstärkte Ionenaustauschermembran und Verfahren zur Herstellung derselben.
DE68916092D1 (de) Schweisshemmende Mittel und Verfahren zur Herstellung.
DE3677349D1 (de) Kuenstliche lunge des membrantyps und verfahren zu ihrer herstellung.
DE3671375D1 (de) Hartgewebeprothese und verfahren zu ihrer herstellung.
DE3885304D1 (de) Zubereitung für zahnbehandlung und verfahren zur herstellung.
DE3582371D1 (de) Oxindolverbindungen, diese enthaltende zusammensetzungen sowie verfahren zur herstellung derselben.
ATA200786A (de) Skischuh und verfahren zur herstellung desselben
DE3886211D1 (de) Gereinigter Guajakolharz und Verfahren zu seiner Herstellung.
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3762733D1 (de) Keramischer formkoerper und verfahren zu seiner herstellung.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time